Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
How Investors May Respond To Zymeworks (ZYME) Hiring EcoR1 Executives To Lead R&D And Deals [Yahoo! Finance]
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 [Yahoo! Finance]
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth [Yahoo! Finance]